Proliferation and differentiation of rat adipose precursor cells in chemically defined medium: differential action of anti-adipogenic agents.
Primary rat adipose precursor cells, maintained in the minimal chemically defined medium (ITT medium) able to promote differentiation, have been used to investigate the ability of several agents to modulate their proliferation and their differentiation. Fetuin and fibroblast growth factor (FGF), which exhibited a strong and a weak mitogenic activity, respectively, do not significantly affect the proportion of differentiated cells as indicated by glycerol-3-phosphate dehydrogenase (GPDH) activity values. In contrast, carbaprostacyclin (cPGI2), a stable analogue of prostacyclin, behaves as a true adipogenic factor leading to a 4 to 5-fold increase in GPDH-specific activities with no significant effect on cell growth. Submaxillary gland kallikrein (SMGK), transforming growth factor-beta (TGF-beta) and tumor necrosis factor-alpha (TNF-alpha) behave as growth-promoting agents but at the same time elicit a dose-dependent inhibition of differentiation. Epidermal growth factor (EGF) and prostaglandin F2 alpha (PGF2 alpha) do not show any effect on cell proliferation at concentrations which exert a maximal inhibitory action on differentiation. Upon removal of EGF from the culture medium, complete resumption of differentiation occurs, whereas upon removal of PGF2 alpha or SMGK, complete resumption only takes place when differentiation is triggered by cPGI2. Upon removal of TNF-alpha, a partial resumption of differentiation is observed, whereas no subsequent differentiation is observed upon TGF-beta removal. These results emphasize the adipogenic, nonmitogenic role of cPGI2 and also allow the distinction between the various adipogenic/mitogenic factors which affect adipose cell differentiation.
Centre de Biochimie (UMR 134 CNRS), Université de Nice-Sophia Antipolis, Faculté des Sciences, France.
G
G
Vassaux
R
R
Négrel
G
G
Ailhaud
D
D
Gaillard
D017667:Adipocytes / Q000166:cytology*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D003470:Culture Media; D011464:Epoprostenol / Q000031:analogs & derivatives / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology; D007610:Kallikreins / Q000494:pharmacology; D008297:Male; D008934:Mitogens / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013234:Stem Cells / Q000166:cytology*; D013268:Stimulation, Chemical; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D003470:Culture Media; D006133:Growth Substances; D008934:Mitogens; D014409:Tumor Necrosis Factor-alpha; C026678:carboprostacyclin; D011464:Epoprostenol; D007610:Kallikreins